The first thing every independent medspa loses to AI engines is the brand fight. Not because the practice is invisible — most book three to five months out on Google — but because ChatGPT, Claude, and Perplexity are answering “best Botox in [city]” with the manufacturer.
What is the Allergan AI citation monopoly?
In 2026, Allergan and AbbVie capture 90%+ of medical-aesthetic AI citations. RealSelf takes about 75%. Ideal Image holds 65%, LaserAway 55%, Galderma 50%, Sono Bello 40%, SkinSpirit 25%, Aedit 20%. The average independent medspa lands below 1% per Metricus’s 2026 audit. The Haute MD and 5WPR Medical Aesthetics AI Visibility Index, released April 25 2026, found the top 15 brands capture 62% of total citation share. The fix is not a brand fight — it is procedure × metro arbitrage.
This is the citation hierarchy every American Med Spa Association member is waking up to. The medspa industry crossed $20 billion in revenue in 2025, with roughly 8,000 to 10,000 practices in the US — 81% of them single-location operators. Metricus projects $45.5 billion by 2030 at a 14.6% CAGR. And the buyer is now arriving through a different funnel: 40% of patient searches will use AI by year-end 2026 per Cornflower’s industry survey, and “Botox near me” alone clears one million monthly searches.
The buyer is asking the engine. The engine is answering with Allergan.
This cluster sits inside the medspa playbook hub and pairs with the Texas SB 378 medspa website audit on the regulatory angle that lifts compliant practices above the brand floor.
What the 8-tier medspa AI citation hierarchy looks like in 2026
Per the Metricus MedSpa AI Visibility 2026 audit, the verified citation tiers stack like this:
| Rank | Entity | Type | AI mention rate (2026) |
|---|---|---|---|
| 1 | Allergan / AbbVie (Botox, Juvéderm) | Manufacturer | 90%+ |
| 2 | RealSelf | Marketplace | ~75% |
| 3 | Ideal Image | National chain | ~65% |
| 4 | LaserAway | National chain | ~55% |
| 5 | Galderma | Manufacturer | ~50% |
| 6 | Sono Bello | National chain | ~40% |
| 7 | SkinSpirit | Regional chain | ~25% |
| 8 | Aedit | Marketplace | ~20% |
| — | Average independent medspa | 1-3 locations | <1% |
Two independent audits agree on the shape. Metricus measured the per-tier AI mention rate. The Haute MD and 5WPR Medical Aesthetics AI Visibility Index released April 25 2026 — the first published audit in the category — ran 60-plus queries across ChatGPT, Claude, Perplexity, and Google AI Overviews against 25 brands, and reported that the top 15 brands capture 62% of total AI citation share. The top five Haute MD brands are Botox, Juvéderm, CoolSculpting, SkinCeuticals, and Morpheus8. Three of those five are Allergan or AbbVie products. Two are owned by competitors that nonetheless pay manufacturers and marketplaces to reinforce the same flywheel.
Underneath that visible hierarchy sits a second layer: Reddit. The 5W AI Platform Citation Source Index 2026 lists Reddit as the number-one cross-LLM citation source — r/30PlusSkinCare, r/SkincareAddiction, and r/PlasticSurgery overlap heavily on injector and procedure threads. The branded-product flywheel feeds Reddit citation; Reddit citation feeds back into the LLM. The independent medspa is not in either loop.
Why brand-level dominance hides 8,000 to 10,000 independent medspas
The structural cause is not algorithmic. It is entity-graph density.
Allergan and AbbVie publish a server-rendered, schema-complete entity for every product: Botox.com, Juvederm.com, the Allē rewards programme, the Brilliant Distinctions legacy domain, the manufacturer-side provider locator. Each of those entities cross-links to medical literature, FDA filings, peer-reviewed efficacy data, and a decade of earned media. ChatGPT verifies what it can cite. The branded entity always verifies first.
The average independent medspa publishes one Squarespace 7.1 site with auto-injected LocalBusiness schema it cannot edit, a canonical tag locked at the platform level, and no path to add MedicalBusiness, Physician, MedicalProcedure, or FAQPage JSON-LD without bouncing into the static-rebuild conversation. The Squarespace AI Visibility tool diagnoses the gap; it does not raise the schema cap or move JSON-LD to server-side rendering. The platform-level constraint is the same shape detailed in the Squarespace canonical trap — and Squarespace dominates the boutique medspa template market by design.
The result: 8,000 to 10,000 US medspas compete for the long tail below 1% AI mention rate. Generic SEO playbooks — keyword density, blog cadence, off-page links — do not dent this. The medspa SEO agencies clustered in the vertical (Pronk MedSpa Marketing, Cornflower, Keygrow, Inboundmedic, Wowbix’s 2026 ranking) publish content into a citation pipeline that is already 90%-captured at the brand layer before a patient prompt is ever typed.
This is the same concentration shape that shows up in adjacent verticals. The named-surgeon citation theft report maps the analogous brand-vs-named pattern in plastic surgery, where ASPS and RealSelf hold the top tier and individual surgeons cite below the floor. The findlaw / Avvo / Justia citation share breakdown maps the analogous concentration map in legal directories. The shape repeats; the fix repeats with it.
How Haute MD’s April 25 2026 index changed the conversation
Before April 25 2026, no published audit measured medical-aesthetic AI citation share. The Metricus number existed inside one vendor’s blog. The category had no benchmark.
The Haute MD and 5WPR Medical Aesthetics AI Visibility Index changed that. Released through Haute Living and PR Newswire, it ran 60-plus queries across the four major engines — ChatGPT, Claude, Perplexity, Google AI Overviews — against 25 named brands in the $22 billion global aesthetics market. The output: a brand-level league table with Botox, Juvéderm, CoolSculpting, SkinCeuticals, and Morpheus8 in the top five and the top 15 capturing 62% of total citation share. The methodology is reproducible. The headline is citable.
What the index did not do is go below the brand layer. It does not name a single individual injector, surgeon, or single-location medspa. It does not publish per-metro citation share. It does not run weekly. The provider-level citation map — which named medspa ChatGPT recommends for Botox in San Antonio this week, which named injector for lip filler in Manhattan, which named provider for CoolSculpting in Miami — is an open data category.
The Haute MD index is the proof that the brand layer is captured. It is also the implicit invitation to publish the layer underneath it.
The procedure × metro arbitrage that beats brand citation
The arbitrage for an independent medspa is not “outrank Allergan on Botox”. That is unwinnable. The arbitrage is the layer Haute MD does not publish.
Three axes compound. First, procedure-level: not “Botox” but “Botox vs Dysport for forehead lines”, “Sculptra vs Radiesse”, “Morpheus8 vs Profound RF”, “lip filler longevity by product”. The Metricus and Cornflower verified buyer-prompt list runs to fifteen high-intent queries that go below the brand. Second, metro-level: “top RealSelf-rated injector Houston”, “where to get Morpheus8 in Manhattan”, “safest laser hair removal LA”, “best HydraFacial Miami”. Local-intent prompts collapse the Allergan brand floor because the buyer is asking for a provider, not a product. Third, week-of: AI citation drift is real. The 5W index measures cross-engine source change; the named-provider layer drifts faster than the brand layer. A weekly scan converts drift into a publishable index.
The fix is structural too. To compete at the provider × procedure × metro layer, the medspa needs an entity graph the engine can verify — MedicalBusiness plus Physician (one record per injector with hasCredential) plus MedicalProcedure (one record per service, with brand association) plus FAQPage plus Review, all server-rendered, all in the initial HTML response. The full architecture lives in the entity-graph schema that lifts an independent above the brand floor. The cluster that ports that architecture into the medspa-specific compliance angle — Texas SB 378, Florida HB 1429, the NYC December 2025 enforcement bust — is the Texas SB 378 medspa website audit, which is the regulatory angle that lifts compliant practices into citation share.
Generic SEO playbooks fail here because the citation pipeline is not a ranking pipeline. Earned media drives 84% of AI citations across ChatGPT, Claude, and Gemini per Generative Pulse’s May 2026 report; paid and advertorial content drives 0.3%. Backlinks-as-a-service does not move the needle. Server-rendered entity, named-provider authority, and per-procedure per-metro freshness do.
The Wave-1 medspa data drop cadence
ConnectEra’s Wave-1 medspa data drop runs weekly across ten metros: New York, Los Angeles, Miami, Houston, San Antonio, Dallas, Phoenix, Chicago, Atlanta, and San Diego. Each Wednesday the same four prompt sets fire across ChatGPT, Claude, Perplexity, and Google AI Overviews — Botox, lip filler, CoolSculpting, Morpheus8 — at the metro level. Every cited provider URL is logged. Every named injector citation is counted. The weekly index publishes the procedure × metro × engine breakdown that no existing audit covers.
The output is two things at once. For named medspas that show up in the index, a public citation record that compounds in the entity graph. For medspas that do not, an audit-grade gap report that points at the platform constraint, the schema gap, the entity-graph absence, or the freshness deficit responsible. Either way, the data category — provider-level medspa AI citation share, week-of, by metro — moves from empty to published, with the medspa-vs-Allergan baseline finally measured at the layer that matters to the buyer.
The brand citation pipeline is captured. The provider citation pipeline is open.
